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Although most Mtb infections do not lead to the manifestation of clinical disease, few studies have focused on delineating the immune factors that are associated with the asymptomatic states that comprise latent tuberculosis infection (LTBI). To broadly characterize this immune state, we used high-dimensional cytometry by time-of-flight (CyTOF), a proteomics technology that assesses the abundance of cell subsets, protein expression and activation of signalling pathways at the single-cell resolution 4 (Fig. 1a) . We analysed peripheral blood mononuclear cells (PBMCs) from uninfected and latently infected adolescents (aged 13-18 years) from South Africa (Supplementary Table 1 ). This cohort is from a highly endemic area but has a lower rate of active tuberculosis (TB) than is seen in young children and adults 5 , indicating a well-controlled Mtb infection. Table 2 ) of 14 uninfected controls and 14 individuals with LTBI identified four cell subsets (defined by cell-surface protein expression) with a significantly higher percentage (of total live cells) in individuals with LTBI than uninfected controls (false discovery rate (FDR) of <1%). These four subsets comprised total CD16-expressing cells, natural killer (NK) cells and two closely related populations of CD27 − CD8 + αβ T cells that differed in their CD38 expression. By contrast, two other cell subsets, total B cells and naive B cells, were significantly less abundant in individuals with LTBI ( Fig. 2a and Extended Data Fig. 1a-c ). Similar differences in NK cell and B cell percentages between uninfected controls and individuals with LTBI were also observed in an additional 20 individuals analysed by CyTOF, and another 32 individuals analysed by flow cytometry (Extended Data Fig. 1d ). Because latently infected individuals show no significant change in peripheral monocyte or lymphocyte counts compared to uninfected controls 6, 7 , changes in the percentage of a given cell type most likely reflect corresponding alterations in its abundance.
An initial analysis (Supplementary
Significant differences in the percentage of immune effector cell subsets between samples from uninfected controls and individuals with LTBI were also identified. Granzyme B (GZMB) and perforin (PRF) expressing cells were significantly higher in individuals with LTBI. These mostly consisted of NK cells and GZMB + PRF + IFNγ + TNF + polyfunctional cells, which largely comprised CD27 − CD8 + αβ T cells, but also included NK cells and γδ T cells ( Fig. 2b and Extended Data Fig. 2a-c ). These cells also expressed significantly higher levels of GZMB (Extended Data Fig. 2d, e) , indicating an enhanced cytotoxic potential on a per-cell basis. Indeed, NK cells from individuals with LTBI showed significantly higher target cell lysis than those from uninfected controls (n = 10 per group, P = 0.003; Fig. 2c ). Additionally, there were higher percentages of CD16 + GZMB high cells within the compartments of the NK cells, CD8
+ αβ T cells and γδ T cells in PBMCs from individuals with LTBI ( Fig. 2d and Extended Data Fig. 2f ). PBMCs from individuals with LTBI also mounted significantly higher antibody-dependent cell-mediated cytotoxicity (ADCC) responses than those from uninfected controls (n = 12 per group, P = 0.006; Fig. 2e and Extended Data Fig. 2g ). ADCC allows antibodies, in addition to T cells, to contribute to the antigen-specific cytotoxic response. In this context, it was reported that antibodies from individuals with LTBI, compared to those from patients with active TB, have unique Fc functional profiles that promote selective binding to CD16 and effectively drive intracellular Mtb killing 8 . The ability of cells to respond to immune challenges is an important factor in maintaining host immune competence. To determine the signalling Letter reSeArCH capacity of immune cells, we used CyTOF (Supplementary Table 2 ) to investigate their ability to transiently phosphorylate signalling effectors in response to PMA and ionomycin, IFNγ, TNF or combined anti-CD3 and anti-CD28 stimulation. We found that in individuals with LTBI, all T cell subsets exhibited diminished responsiveness through the S6 signalling pathway, irrespective of the stimulation condition, with the exception of γδ T cells after stimulation with both anti-CD3 and anti-CD28, as compared to cells from uninfected controls (Fig. 2f) Fig. 2f ). e, ADCC response of total PBMCs from uninfected controls and individuals with LTBI (n = 12 per group) as determined by antibody-mediated killing of CFSE-labelled target (P815) cells (Extended Data Fig. 2g) 
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Although alterations in the T cell compartment in individuals with LTBI did not lead to alteration in the levels of T cells in the periphery (Extended Data Fig. 1e ), changes in the B cell compartment resulted from a decrease in the abundance of total B cells, which was largely driven by a reduction in circulating naive B cells. Reductions in the levels of peripheral B cells could be due to preferential sequestration of these cells at the site of infection (lungs and associated lymph nodes) and/or altered output of B cells from the bone marrow; inflammation can lead to enhanced myelopoiesis with diminished B cell output 10 . Analysis of 184 plasma proteins (Supplementary Table 3 ) showed significantly higher levels of inflammation-associated molecules, such as CXCL8 (also known as IL-8; P = 0.01), adenosine deaminase (ADA; P = 0.035) and NAD kinase (NADK; P = 0.004) in samples from individuals with LTBI relative to uninfected controls (n = 27 per group). By contrast, the plasma levels of CCL23, which has been shown to inhibit myelopoiesis 11 , was significantly lower in individuals with LTBI (P = 0.02; Fig. 2g and Extended Data Fig. 3 ), suggesting altered myelopoiesis in LTBI. Taken together, our results identified multiple immune components that operate together in LTBI. Specifically, in the presence of ongoing inflammation coupled with deviations in B and T cell compartments, enhanced cytotoxic responses that are mostly mediated by CD16 and NK cells appeared to be key factors associated with maintaining latency, which we propose represents successful immune control of Mtb infection.
Because alterations in peripheral immune cell distributions have not previously been commonly associated with TB latency, we tested whether such changes were observed in other LTBI cohorts, including those of children and adults (Fig. 1b) . Although their PBMCs were not available for analysis, transcriptional profiles of whole-blood or PBMC samples from these cohorts were publicly available. We applied a computational approach to infer leukocyte representations from geneexpression profiles using support vector regression 12 with the leukocyte expression signature matrix 'immunoStates' 13 . Analysis of geneexpression datasets from 189 uninfected controls and 145 subjects with LTBI from six clinical cohorts (Supplementary Table 4) , including children and adults from four continents, showed that NK cells were significantly more abundant (FDR = 0.018%) in cohorts of individuals with LTBI (Fig. 3a) . Changes in B cell percentages were heterogeneous across the cohorts. However, analysis from all cohorts combined indicated a significant reduction in the percentages of total B cells (FDR = 1%) and naive B cells (FDR = 0.38%) in samples from individuals with LTBI ( Fig. 3a and Extended Data Fig. 4a ). No significant differences in total T cell abundance (FDR = 74%) (Fig. 3a) or those of the CD4 + and CD8 + subsets (FDR = 44% for both subsets; Extended Data Fig. 5a ) were observed between the uninfected and LTBI cohorts. Thus, the analyses from multiple LTBI cohorts were consistent with our findings obtained from the cohort of South African adolescents.
To evaluate whether and how these immune cell frequencies change during active disease, we analysed transcriptome profiles from PBMC or whole-blood samples from 409 individuals with LTBI and 543 patients with active TB from nine clinical cohorts (Supplementary  Table 4 ), profiling children and adults, with and without HIV comorbidity, across three continents. Deconvolution estimations showed that NK cells were present at significantly (FDR = 0%, P < 2.2 × 10 −16 ) lower frequencies in samples from patients with active TB, with notable consistency across all cohorts (Fig. 3b) . Flow cytometry analysis of whole-blood samples from adults collected from 24 uninfected controls, 17 individuals with LTBI and 23 patients with active TB (Supplementary Table 5 ) from a non-endemic region (Shenzhen) in China also confirmed the stage-specific changes in NK cell frequencies (Fig. 3d) .
Our deconvolution estimations also showed significantly reduced levels of B cells in patients with active TB compared to uninfected individuals (Extended Data Fig. 6 ). The analysis of B cells in an adult Italian cohort is one such example 7 . In general, the decrease in the frequencies of B cells and naive B cells was observed in either latency or active disease relative to uninfected individuals (Fig. 3a, b and Extended Data Fig. 4a, b) , with the exception of an Indonesian cohort, in which no change in B cell frequencies was observed. Notably, similar to the Indonesian cohort, no change in B cell frequencies was observed in the adult Chinese cohort, assessed by flow cytometry (Fig. 3d ). These observations underscore the heterogeneity of immune states in Mtb infection. Although our South African adolescent cohort showed no significant changes in T cell abundance between uninfected controls and individuals with LTBI, both CD4
+ and CD8 + αβ T cell populations showed significantly diminished responsiveness through the S6 pathway, which may foretell the eventual drop in peripheral T cell levels observed in patients with active TB (Fig. 3b, Extended Data Fig. 5b ). 
Flow cytometry assessment of the Chinese cohort confirmed the significant decrease in peripheral T cell levels in patients with active TB compared to uninfected controls (Fig. 3d) . Whether reduced T cell signalling capacity is a common feature of LTBI requires further analysis. Nonetheless, our results suggest that immune deviations in both T and B cell compartments start in latency and progress further in active disease.
To test whether the disease-induced reductions in peripheral lymphocyte populations recover after successful treatment, we deconvoluted PBMC or whole-blood transcriptome profiles of 76 samples from patients with active TB and 97 samples from patients at the end of treatment from four independent cohorts of HIV-negative adults (Supplementary Table 4 ) from three continents. NK cell frequencies, together with all major immune cell populations, except CD4 + αβ T cells, were significantly higher in successfully treated individuals relative to patients with active TB, reaching reference levels observed in healthy, Mtb-uninfected individuals ( Because of the apparent correlation between changes in NK cell frequencies and the stages of Mtb infection, we tested whether the levels of peripheral NK cells could inform TB disease progression and response to treatment (Fig. 1c) by analysing three independent longitudinal follow-up studies of South African cohorts, which included individuals who (1) acquired latent Mtb infection (defined as converting from QuantiFERON (QFT)-negative to QFT-positive), (2) progressed from latent infection to active disease (South African adolescent progressor cohort) 15, 16 and (3) proceeded from active disease to treatment completion (Catalysis-TB cohort) 17 . Deconvolution estimations showed that relative to pre-infection, levels of NK cells did not change significantly after acquisition of Mtb infection (n =17; Fig. 4a ) and decreased during the progression from latent infection to active disease (n = 17; Fig. 4b (left) ). Consistent with this latter computational finding, flow cytometry analysis of 32 individuals with LTBI (12 progressors and 20 non-progressors) ( Supplementary Table 6) showed that NK cell frequencies decreased in each of the progressors, 0-180 days before TB diagnosis, whereas the non-progressors showed no significant change in peripheral NK cell frequencies during the two-year study period (Fig. 4b (right) ). Statistical analysis of the predictive power of NK cell levels for progression to active disease using receiver operating characteristic curves showed an area under the curve of 0.69 (95% confidence interval 0.57-0.82) in the seven months preceding TB diagnosis (Fig. 4c) . In addition, deconvolution analysis of gene-expression data from the Catalysis Foundation for Health study of patients with active TB under treatment showed that in individuals who responded to treatment (classified as 'definite cure' , n = 76), NK cell levels were significantly higher at the end of treatment (week 24) compared to baseline (pre-treatment, P < 0.0001; Fig. 4d ). By contrast, treatment non-responders (classified as 'no cure' , n = 7), showed no significant change in their NK cell percentages between baseline and end of treatment (P = 0.1250; Fig. 4d ). Furthermore, we found that the inflammatory burden of the lung indicated by the total glycolytic activity index, as measured by PET-CT 14 , inversely correlated with peripheral NK cell frequencies at diagnosis (pre-treatment; Fig. 4e ) and at week 4 after treatment initiation (Extended Data Fig. 8 ). Therefore, changes in peripheral NK cell levels reflect changes in the activity level and burden of Mtb in the lung. These observations support the view that circulating NK cells reflect key features of the host immune state, can serve as surrogates of the immune response at the nidus of infection and that longitudinal measurements of peripheral NK cells can inform disease progression and treatment efficacy. Table 6 ) were determined by cell-mixture deconvolution (17 progressors and 41 non-progressors) (left) and flow cytometry (12 progressors and 20 non-progressors) (right). All P values were derived using a Wilcoxon rank-sum test. Mean and error bars representing the 95% confidence intervals are shown. c, Receiver operating characteristic curves of the potential of estimated NK cell frequencies as a predictor of TB disease progression. d, Estimated NK cell percentages in patients with active TB from the Catalysis-TB cohort at baseline (pre-treatment) and at various time points during treatment. Definite cure indicates sputum culture negative by month 6 after treatment initiation (n = 76); no cure indicates sputum culture positive after six months of treatment initiation (n = 7). P values were derived using a Wilcoxon rank-sum test. Mean and error bars representing the 95% confidence intervals are shown. e, Correlation plot showing the relationship between estimated peripheral NK cell frequencies in patients with active TB at baseline (pre-treatment) and total glycolytic activity index (TGAI) measured by PET-CT imaging of the lungs at baseline. The line represents the best fit and the shaded area the 95% confidence interval. NK cell frequencies were determined by deconvolution. 
noted for controlling HIV infections 22 .
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-018-0439-x. ). All participants were healthy without signs or symptoms of active disease. Only adolescents who remained disease-free for two years from the time of enrolment were included in the analysis.
Cohorts associated with publicly available datasets 27-37 that were used for the analysis of immune cell distributions at different stages of Mtb infection, and end-of-treatment, by cell-mixture deconvolution, are described in Supplementary  Table 4 .
An adult Chinese cohort (Supplementary Table 5 ) from Shenzhen, a nonendemic region in China was assessed for immune cell distributions at different stages of Mtb infection using flow cytometry analysis of PBMC samples. Individuals were defined as latently infected if diagnosed positive by the interferon gamma release assay (IGRA + ) but showed no symptom or chest X-ray signs suggestive of active disease. Tuberculosis was defined as intrathoracic disease with positive sputum smears and/or cultures for Mtb. The study protocols were approved by the relevant human research ethics committees.
Three independent longitudinal South African progressor cohorts were analysed for the kinetics of the frequency changes in NK cells using deconvolution of gene expression datasets. These cohorts transitioned from: (1) an uninfected state to latency (GSE116014), for which samples were obtained from an Mtb-acquisition sub-cohort, selected from the larger ACS cohort 5, 16 , who were diagnosed as QFT-negative at multiple time points, six months apart, and then converted to QFT-positive, indicating a newly acquired Mtb infection (Extended Data Fig. 9) ; (2) latency to active disease, individuals enrolled in the ACS cohort described above, were assessed longitudinally every six months during a 2-year follow-up study 15 . Adolescents who developed active tuberculosis disease during this 2-year follow-up were included as 'progressors' , and those who did not, were classified as LTBI 'non-progressors' (Supplementary Table 6 ). Active TB was defined as intrathoracic disease, with either two sputum smears that were positive for acid-fast bacilli or one positive sputum culture confirmed to be M. tuberculosis complex (mycobacterial growth indicator tube, BD BioSciences). Participants were excluded if they were known to be HIV-positive; (3) active disease to end-of-treatment, the Catalysis-TB cohort 17 .
Mass cytometry measurements and analysis.
CyTOF experiments were performed as previously described 38 . In brief, cryopreserved PBMCs were thawed and rested in complete RPMI with 10% FCS at 37 °C for 2 h at cell densities of approximately 10 7 cells per ml. Cells from each sample were equally split into two parts and were either left untreated or stimulated for 4 h with 150 ng ml −1 phorbol-12-myristate-13-acetate (PMA) and 1 μM ionomycin in the presence of brefeldin A and monensin (eBioscience). Cells (5 × 10 6 ) were then stained (1 h; room temperature) with a mixture of metal-tagged antibodies (a complete list of antibodies and their catalogue numbers is provided in Supplementary Table 2). All antibodies were validated by the manufacturers for mass cytometry applications (as indicated on the manufacturer's datasheet, available online) and were conjugated using MAXPAR reagents (Fluidigm Inc.). Cisplatin and iridium intercalators were used to identify live and dead cells. We used palladium barcoding (Fluidigm Inc.) according to the manufacturer's instructions. Cells were washed twice with PBS, fixed in 1.6% paraformaldehyde (PFA) (Sigma-Aldrich; 1 h), washed again in ultrapure water and analysed using CyTOF mass cytometry on a CyTOF 2 instrument (Fluidigm). Intracellular phosphorylated-protein staining was carried out as previously described 39 . In brief, cryopreserved PBMCs were thawed and rested as described above. Rested cells were incubated with cisplatin for 1 min and immediately quenched with four volumes of complete RPMI with 10% FCS, and rested again for 30 min at 37 °C. Subsequently, cells were split into five tubes; one was left untreated and the others were stimulated with (1) PMA and ionomycin, (2) IFNγ (50 ng ml ) and anti-CD28 (2 μg ml −1 ) for 15 min at 37 °C. The reaction was stopped by adding PBS with 2% PFA (incubated for 10 min; room temperature), followed by palladium barcoding as recommended by the manufacturer (Fluidigm). After barcoding, cell samples were washed and then combined for surface-marker staining (1 h; room temperature). Subsequently, cells were washed and permeabilized in MeOH at −80 °C overnight. The next day, cells were washed and incubated with the cocktail of antibodies to intracellular signalling proteins at room temperature for 1 h, followed by DNA staining as described above.
Cell events were acquired at approximately 500 events s −1 . In addition, we spiked each sample with internal metal-isotope bead standards for sample normalization using the CyTOF software (Fluidigm Inc.). Data processing and gating of dead cells and normalization beads was done on the Cytobank website (http:// www.cytobank.org). To account for intra-run declines in mean marker intensity over time, we performed a within-sample-over-time normalization step by using a running window to adjust mean marker intensity throughout each individual run, such that the mean expression over time was equal to that measured at the beginning of the run. Data was debarcoded using Fluidigm's Debarcoder tool. Data was arcsinh-transformed for analysis. Analysis of CyTOF data. Citrus (cluster identification, characterization and regression). Cell subset abundance and functional marker expression in PBMCs from uninfected controls and subjects with LTBI were compared using the Citrus algorithm available from the Cytobank website. Citrus 40 uses regularized supervised learning algorithms to identify stratifying clusters (subsets) and cell response features. It is data driven and corrected for multivariate comparisons. In brief, Citrus analysis consists of the following steps. First, FCS files of normalized, 'live cell/no beads' samples were randomly sampled for n single-cell events. Second, collected single-cell events were pooled and iteratively hierarchically clustered based on similarity of expression of subsets of the measured channels. This procedure yielded overlapping clusters with the largest cluster encompassing all of the sampled events. Third, the pooled dataset was split back into its constitutive samples, and the relative abundance of cells in each cluster was computed, as well as the median expression of each functional marker in each cluster. Only clusters for which the abundance in one or more of the measured samples was greater than some lower-bound P values were considered for downstream differential analysis. Fourth, to determine differences in cell subset abundances or functional marker medians expression, we used the SAM algorithm in Citrus, which assesses FDR by permutations. For each set of analysis, we set n to 20,000 and the clustering threshold to 1% of total cells and performed the analysis iteratively such that 20,000 events from the entire dataset were chosen randomly for the multiple rounds of analysis. We also analysed the entire dataset in R. These analyses yielded qualitatively similar results.
Analyses of abundance from unstimulated and stimulated samples were done separately (see Extended Data Figs. 1, 2) because stimulation changed the expression levels of certain cell-surface markers. Manual inspection of Citrus output was used to identify the closest known gross-cell type. We characterized cell clusters using standard cell subset definitions: B cells (CD19 + ), CD8 + αβ T cells (CD3
). In all conditions, we report cluster abundance differences at a FDR < 1%. viSNE analysis. Single-cell analysis using the dimensionality reduction technique viSNE reduces the multi-parametric data into two dimensions for visualization of similarity and heterogeneity across individual cells 41 . To account for different scales between parameters, the data was arcsinh transformed. viSNE analysis was performed on raw CyTOF data from the Cytobank database. Manual gating. Manual gating was performed on the Cytobank website on normalized, debarcoded data files. A hierarchical gating strategy was used to identify live, single cells of the main PBMC populations (Extended Data Fig. 1a) and their subsets based on the expression of surface, cytokine or signalling molecules. NK cell cytotoxicity measured by calcein-release assay. NK cells were enriched from PBMCs using the NK Cell Isolation Kit from Miltenyi Biotech. The NK cell cytotoxicity assay was carried out as described 42 with some modifications. In brief, after cell counting, NK cells were mixed with calcein-acetoxymethyl (calcein-AM) labelled target K562 cells (which are susceptible to NK cell-mediated killing because of the lack of surface MHC class I expression), at an effector to target ratio of 2:1. For staining of the target cells, 2 mM of calcein-AM (Life Technologies) was added to the target cells (2 × 10 6 per ml) and incubated at 37 °C for 30 min with periodic mixing. The target cells were washed, the enriched NK cells were added, and the mixture was incubated at 37 °C for 4 h. Maximum and spontaneous release controls were set up as three replicates using 1% Triton X-100 (final concentration) and plain medium, respectively. After the 4-h incubation, the cells were gently mixed to evenly distribute the released calcein in the supernatant and the plate was spun at 400g for 2 min to pellet the cells and any debris. For the calcein-release assay, 150 μl of the supernatant was collected and transferred to a flat black-bottom plate. The fluorescence was read using a FlexStation3 microplate reader (excitation/emission: 485/530 nm). The percentage of specific lysis was calculated using the formula: ((test release − spontaneous release)/(maximum release − spontaneous release)) × 100. FcγR-mediated antibody-dependent cell mediated cytotoxicity. ADCC was carried out as previously described 43 with some modifications. In brief, P815 cells (a mouse leukaemia cell line) were stained with 0.25 μM carboxy-fluorescein succinimidyl ester (CFSE; Molecular Probes) and incubated with the 10 μg ml
Letter reSeArCH concentration of the P815-specific monoclonal antibody, 2.4G2. Coated and uncoated P815 cells were then cocultured with previously cryopreserved PBMC samples at an effector:target ratio of 10:1 in 10% FCS, penicillin, glutamine and streptomycin. The percentage of target cells that were killed through ADCC was monitored by flow cytometry staining using 7-amino-actinomycin D (7-AAD) viability staining solution (BioLegend). The percentage of cells killed by FcγR-mediated ADCC was obtained by subtracting the percentage 7-AAD + CFSElabelled uncoated target cells from the percentage of 7-AAD + CFSE-labelled coated target cells. A minimum of 300,000 cells were analysed on a BD LSRII, and analysis was then performed using FlowJo (version 10.2) software. Plasma protein quantification using a proximity extension assay. For analysis, 20 μl of frozen (−80 °C) plasma samples were thawed and sent to Olink Proteomics. In proximity extension assays, plasma proteins were dually recognized by pairs of antibodies coupled to a cDNA strand that ligates when brought into proximity to its target, extended by a polymerase and detected using a BioMark HD 96 × 96 dynamic PCR array (Fluidigm). The quantification cycle (C q ) values from a DNA extension control are subtracted from the measured C q value, an interpolate control is corrected for, and finally a correction factor is subtracted to yield a normalized protein expression value, which is log 2 -transformed. Cell-mixture deconvolution and cell percentage meta-analysis. This was carried out as previously described 12, 13 . In brief, publicly available gene expression datasets were collected, pre-processed using the MetaIntegrator R package 44 and annotated 45 . Each microarray dataset was converted into a gene-expression matrix, whereas for GSE79362 15, 16 , which is an RNA-seq dataset, the total read counts per gene were first computed. A Hedge's g effect size was then computed to estimate changes in cell subset proportions. Effect sizes from all individual datasets were integrated into a summary effect size and significance was computed as previously described 44, 46 . To delineate cell trajectories over time, we computed a cumulative effect size score for each cell type in uninfected controls, LTBI, active TB disease, and end-of-treatment stages. We started by setting a reference effect size of 0 for healthy, Mtb-uninfected controls and then computed all following scores by adding the summary effect size value corresponding to case class for that specific comparison (LTBI, active TB, treated). We computed cumulative standard errors by assuming summary effect sizes to be normally distributed and independent of each other at each stage. Plots and statistics were generated using the R programming language. Analysis of cell abundance using flow cytometry. For flow cytometry experiments, PBMCs were thawed and rested as described in 'Mass cytometry measurements and analysis' . Cells (3-5 × 10 6 ) were incubated with antibodies for 30 min at 4 °C, then washed with FACS staining buffer (PBS containing 1% bovine serum albumin and 0.05% sodium azide). The following monoclonal antibodies were used: Pacific Blue-conjugated anti-CD3 (BioLegend, 300417), PE-Cy7-conjugated anti-CD19 (BioLegend, 302216), APC-Cy7-conjugated anti-CD14 (BioLegend, 325620), APC-conjugated HLA-DR (BioLegend, 307610), PE-Dazzle-conjugated anti-CD16 (BioLegend, 302054) and Brilliant Violet 785-conjugated CD56 (BioLegend, 362550). The live/dead aqua-amine reactive dye was used for gating dead cells. All antibodies were validated by the manufacturers for flow cytometry application, as indicated on the manufacturer's website. Data were analysed using FlowJo version 10.2. Statistical analysis. Analysis of CyTOF data are described in 'Citrus (cluster identification, characterization and regression)' . In all other experiments, significance levels were determined using Prism version 7 (GraphPad Software). Experiments were analysed using the Mann-Whitney U-test or one-way analysis of variance (ANOVA), as indicated for each experiment. The diagnostic performance of NK cells to discriminate latent TB from active disease cases was evaluated using receiver operating characteristic (ROC) curve analysis, for which the true positive rate (sensitivity) is plotted as a function of the false-positive rate (100 − specificity). The area under the ROC curve is a measure of the probability that a classifier (for example, NK cell frequencies) will rank a randomly chosen positive instance (for example, active TB) higher than a randomly chosen negative one (for example, LTBI). ROC curves were plotted using Prism version 7. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Data availability. The data that support the findings of this study are available from the corresponding authors upon reasonable request.
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Extended Data Fig. 1 | Broad alterations of peripheral immune cell distributions in LTBI. PBMCs from 14 latently infected and 14 uninfected participants of a South African adolescent cohort were characterized using CyTOF with antibody panel 1 (Supplementary Table 2) , followed by Citrus analysis and clustering. This unsupervised hierarchical clustering analysis produced a branching structure (dendrogram) that allowed the grouping of total live cells into known immune cell compartments (contoured). Cell clusters are represented as nodes (circles) in this Citrus-derived circular dendrogram, which delineates lineage relationships that were identified from the data. Cluster granularity (that is, cell subset specificity) increases from the centre of the diagram to the periphery. a, Annotation of cluster hierarchy plots based on surface marker expression. The expression intensity of each marker used for cell population characterization is overlaid per cluster on the Citrus circular dendrogram and is indicated, independently for each marker, by the coloured gradient for which the range corresponds to the arcsinhtransformed expression of the median marker expression measured across all Citrus clusters. For each marker, we also provide a dot plot graph demonstrating the marker labelling in the manually gated indicated population. b, Citrus plots showing, based on cell-surface protein expression, clusters (in red, designated A-F) that exhibit significantly different abundances (SAM analysis with FDR < 1%) between the uninfected and latently infected individuals. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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Data collection
No commercial, open-source or custom code was used to collect data in this study.
Data analysis
We used support vector regression with a new gene signature matrix, immunoStates , which is available on BioRXIV (https:// doi.org/10.1101/206466) and thus, publicly available. Flow cytometry data was analyzed using FlowJo (v10). CyTOF data was analyzed using the Citrus algorithm available on cytobank.org. Other statistical analyses were performed using Prism GraphPad (v7).
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Sample size
No sample-size calculations were performed. Sample size was determined to be adequate based on the magnitude and consistency of measurable differences between groups. 1) CyTOF -A total of 28 samples (14 uninfected and 14 latently infected) were used for Citrus analysis, which requires a minimum of 8 samples/group for the fully automated discovery of statistically significant stratifying biological signatures. 14 samples/group was therefore enough to identify clusters of stratifying cellular populations using the Significance Analysis of Microarray (SAM) at an FDR of <1%. For Phospho-CyTOF, 20 samples (10 uninfected and 10 latently infected) were used-based on sample availability.
2) Cell-mixture deconvolution of all publicly available datasets -N/A 3) FACS analysis of adolescent progressor cohort (12 Progressors and 20 Non-progressors) -Sample size was determined based on sample availability. 4) FACS analysis for ADCC/Calcein release assay for NK cytotoxicity -Sample availability and enough required to get statistically meaningful data. 5) FACS analysis for immune cell subset distributions -Sample availability and enough required to get statistically meaningful data. 6) Plasma proteomics -Sample availability.
Data exclusions 1) CyTOF-No data was excluded.
2) Deconvolution analysis of publicly available microarray data in GEO-No data was excluded.
3) Cell-mixture deconvolution of progressor cohorts-(a) Samples that had measurements at both 180 days and 360 days prior to infection diagnosis, the 360 day time point was used in the analysis because that would represent a long enough time before diagnosis of infection for Pre-Post comparisons. (b) Progression from latent infection to active TB disease: Samples that had measurements for at least 2 time points before TB diagnosis were included. We excluded 3 subjects with estimated NK cell frequencies equal to or less than 2% measured >200 days prior to active TB diagnosis, since further progression-associated decreases (if any) would be difficult to measure by deconvolution. Nonprogressors that had measurements for at least 2 time points were included. (c) Progression from active TB disease to end-of-treatment: All samples that were considered either "Cured" or "Non-cured" were included. Definitions of "Cured" and "Non-cured" are explained in the manuscript. 4) FACS analysis for immune cell distributions (ACS cohort/ Chinese cohort)-No data was excluded. 5) Plasma proteomics -No data was excluded.
ChIP-seq Data deposition
Confirm that both raw and final processed data have been deposited in a public database such as GEO.
Confirm that you have deposited or provided access to graph files (e.g. BED files) for the called peaks. 
Data access links
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided. Cell population abundance The study did not involve sorting of cell populations
Gating strategy
The gating strategy is described in the manuscript Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
Magnetic resonance imaging Experimental design
Design type 
